A prospective, multicenter, open-label study of the clinical efficacy of tapentadol extended-release in the treatment of cancer-related pain and improvement in the quality of life of opioid-naïve or opioid-resistant patients

PURPOSE: This study aimed to investigate the clinical efficacy of tapentadol extended-release (ER) on pain control and the quality of life (QoL) of patients with moderate to severe chronic cancer pain in clinical practice in Korea. METHODS: In this prospective, open-label, multicenter trial, patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Ji Yoon, Chon, Hong Jae, Choi, Young Jin, Yeon, Sang Eun, Choi, Seok Young, Lee, Kyung Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135883/
https://www.ncbi.nlm.nih.gov/pubmed/35420330
http://dx.doi.org/10.1007/s00520-022-06992-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135883/
https://www.ncbi.nlm.nih.gov/pubmed/35420330
http://dx.doi.org/10.1007/s00520-022-06992-w

Ejemplares similares